Director Wang (STAA) discloses 3,257,130 indirect STAAR Surgical shares
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
STAAR Surgical director Christopher Min Fang Wang filed an initial ownership report showing indirect beneficial ownership of 3,257,130 shares of common stock. The holdings consist of 2,575,061 shares owned by Yunqi Path Capital Master Fund and 682,069 shares owned by Yunqi China Special Investment A. Through his roles with the Yunqi entities, Mr. Wang may be deemed to beneficially own these shares, but he disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Wang Christopher Min Fang
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock, par value $0.01 per share | -- | -- | -- |
Holdings After Transaction:
Common Stock, par value $0.01 per share — 3,257,130 shares (Indirect, See footnote)
Footnotes (1)
- [object Object]
FAQ
What insider position does Christopher Min Fang Wang hold at STAAR Surgical (STAA)?
Christopher Min Fang Wang is reported as a director of STAAR Surgical. The filing indicates he is not listed as an officer or 10% owner, and the Form 3 is filed as an initial statement of his beneficial ownership relationship with the company.
What type of security is reported in this STAAR Surgical (STAA) Form 3 filing?
The filing covers common stock with a par value of $0.01 per share. It reports indirect beneficial ownership of these common shares, with no derivative securities listed in the derivative securities table for this initial ownership statement.
Is this STAAR Surgical (STAA) Form 3 reporting a transaction or just current holdings?
This Form 3 reflects current beneficial holdings rather than a new trade. The transaction section shows a holding entry tied to 3,257,130 shares indirectly owned following the reported event date, with no specific purchase or sale price disclosed.